Elevated fibroblast growth factor 21 (FGF21) levels in obese, insulin resistant states are normalised by fenretinide treatment via retinoic acid signalling

N. Mody; Nicola Morrice; G. D. McIlroy; K. D. Shearer; P. J. McCaffery; M. Delibegovic

doi:10.1111/dme.5_13048

Elevated fibroblast growth factor 21 (FGF21) levels in obese, insulin resistant states are normalised by fenretinide treatment via retinoic acid signalling

N. Mody, Nicola Morrice, G. D. McIlroy, K. D. Shearer, P. J. McCaffery, M. Delibegovic

Research output: Contribution to journal › Abstract › peer-review

Original language	English
Pages (from-to)	48
Number of pages	1
Journal	Diabetic Medicine
Volume	33
DOIs	https://doi.org/10.1111/dme.5_13048
Publication status	Published - Mar 2016

Access to Document

10.1111/dme.5_13048Licence: Unspecified

Cite this

@article{3430f051b1b44e1db86876cadf2de1d5,

title = "Elevated fibroblast growth factor 21 (FGF21) levels in obese, insulin resistant states are normalised by fenretinide treatment via retinoic acid signalling",

author = "N. Mody and Nicola Morrice and McIlroy, {G. D.} and Shearer, {K. D.} and McCaffery, {P. J.} and M. Delibegovic",

year = "2016",

month = mar,

doi = "10.1111/dme.5_13048",

language = "English",

volume = "33",

pages = "48",

journal = "Diabetic Medicine",

issn = "0742-3071",

publisher = "Wiley",

}

TY - JOUR

T1 - Elevated fibroblast growth factor 21 (FGF21) levels in obese, insulin resistant states are normalised by fenretinide treatment via retinoic acid signalling

AU - Mody, N.

AU - Morrice, Nicola

AU - McIlroy, G. D.

AU - Shearer, K. D.

AU - McCaffery, P. J.

AU - Delibegovic, M.

PY - 2016/3

Y1 - 2016/3

U2 - 10.1111/dme.5_13048

DO - 10.1111/dme.5_13048

M3 - Abstract

SN - 0742-3071

VL - 33

SP - 48

JO - Diabetic Medicine

JF - Diabetic Medicine

ER -